Renamed Bio - About the company
Renamed Bio is a deadpooled company based in Waltham (United States), founded in 1995. It operates as a Developer of renal bio-replacement therapy for compromised kidney function treatment. Renamed Bio has raised $40M in funding. The company has 7 active competitors, including 1 that is funded. Its top competitors include companies like Sentien Biotechnologies, GE Global Research and NorrDia AB.
Company Details
Developer of renal bio-replacement therapy for compromised kidney function treatment. The company focuses on therapies designed to improve clinical outcomes for patients suffering from acute renal failure. Its renal bio-replacement therapy uses human renal epithelial cells to replace lost kidney functions. The therapy is designed for use with current renal replacement therapy in intensive care.
Key Metrics
Founded Year
1995
Location
Waltham, United States
Stage
Deadpooled
Total Funding
Ranked
6th among 7 active competitors
Similar Companies
Sign up to download Renamed Bio's company profile
Renamed Bio's funding and investors
Renamed Bio has raised a total funding of $40M.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Renamed Bio's Competitors and alternates
Top competitors of Renamed Bio include Sentien Biotechnologies, GE Global Research and NorrDia AB. Here is the list of Top 10 competitors of Renamed Bio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Sentien Biotechnologies 2008, Lexington (United States), Series A | Developer of stem cell based device product for acute organ failure | $13M | 45/100 | |
2nd |  GE Global Research 1900, China, Funding Raised | Developer of renal bio-replacement therapy for compromised kidney function treatment | - | - | 36/100 |
3rd |  NorrDia AB Unfunded | Developer of medical devices for the treatment of renal care | - | - | 32/100 |
4th | RenalGuard Solutions 1981, Milford (United States), Late Stage | Innovating AKI prevention with fluid management technology for multiple clinical settings | - | 32/100 | |
5th |  Sonogenix Belmont (United States), Unfunded | Developer of non-invasive device for acute and chronic kidney disease | - | - | 24/100 |
6th | Renamed Bio 1995, Waltham (United States), Deadpooled | Developer of renal bio-replacement therapy for compromised kidney function treatment | $40M | - | 24/100 |
7th |  Lowell Therapeutics 2018, Lowell (United States), Acqui-Hired | Developer of anticoagulant for the treatment of acute kidney diseases | $1M | 19/100 | |
8th |  3ive Labs 2018, Roswell (United States), Unfunded | Developer of devices to restore kidney function | - | - | 19/100 |
9th | CardioRenal Systems Milford (United States), Funding Raised | Manufacturer of medical devices for fluid management and kidney protection | - | 15/100 | |
10th | Kalera Medical 2016, San Diego (United States), Deadpooled | Developer of vaccum-assisted device for kidney stone retrieval | - | 14/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Renamed Bio's competitors? Click here to see the top ones
Renamed Bio's Investments and acquisitions
Renamed Bio has made no investments or acquisitions yet.
Reports related to Renamed Bio
Here is the latest report on Renamed Bio's geography:
Are you a Founder ?
FAQs about Renamed Bio
Explore our recently published companies
- Caffeina - Parma based, 2012 founded, Funding Raised company
- Global Automotive - Kosovo based, 2012 founded, Unfunded company
- Leica Rumors - 2008 founded, Unfunded company
- Bake Or Break - 2006 founded, Unfunded company
- Martinez Landscaping - United States based, 1989 founded, Unfunded company
- Peak Asphalt - United States based, 1997 founded, Unfunded company
